Showing results (1981-1990 of 2,545) with videos related to

Sort By:
Pageof 255
International Urology and Nephrology|January 1, 1995
Impact of the preparation technique on DNA content measured by image analysis in early stage human testis cancerC de Riese, W N Crabtree, W de Riese, et al.
Orthopedic Nursing|November 25, 2020
Impact of a Smartphone App Reminder on Adherence to Aspirin Prescribed as Antithrombotic TherapyDeborah Wittig-Wells, Melinda Higgins, Jessica Carter, et al.
Immunity|August 29, 2020
Multifaceted Effects of Antigen Valency on B Cell Response Composition and Differentiation In VivoYu Kato, Robert K Abbott, Brian L Freeman, et al.
Diabetes, Obesity & Metabolism|January 19, 2021
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetesJonathan M Wilson, Amir Nikooienejad, Deborah A Robins, et al.
Nutrients|November 27, 2021
Acute Metabolic Responses to Glucose and Fructose Supplementation in Healthy Individuals: A Double-Blind Randomized Crossover Placebo-Controlled TrialMax L Eckstein, Antonia Brockfeld, Sandra Haupt, et al.
Journal of the American Geriatrics Society|October 22, 2021
Assessing the concurrent validity of days alive and at home metricErnest Shen, Emily J Rozema, Eric C Haupt, et al.
The Journal of Infectious Diseases|October 16, 2012
Proximity of first sexual intercourse to menarche and risk of high-grade cervical diseaseÁngela María Ruiz, Jaime Enrique Ruiz, Andrés Velásquez Gavilanes, et al.
Journal of Neuroscience Methods|January 18, 2025
A wireless optogenetic setup in freely moving mice for evaluation of cortical spreading depolarization in a chronic disease modelAnnika Köhne, Simeon O A Helgers, Bettina Kewitz, et al.
Pediatrics|May 5, 2010
Safety, tolerability, and immunogenicity of gardasil given concomitantly with Menactra and AdacelKeith S Reisinger, Stan L Block, Michelle Collins-Ogle, et al.
Lancet (London, England)|June 29, 2023
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USAJulio Rosenstock, Juan Frias, Ania M Jastreboff, et al.
Pageof 255